ENvue Medical, Inc.
FEED- Exchange
- OTC
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001326706
No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding ENvue Medical, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 19 | 13 | −6 |
| Shares | 1.83M | 1.45M | −376.4K (−20.6%) |
| Value | $2.12M | $906.0K | −$1.21M (−57.2%) |
New holders (0)
Institutions that held ENvue Medical, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
None.
Sold out (6)
Institutions that held ENvue Medical, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 130,466 | $151.0K |
| Two Sigma Securities, LLC | 38,663 | $45.0K |
| Millennium Management LLC | 30,245 | $35.0K |
| Tower Research Capital LLC (TRC) | 7,038 | $8.00K |
| Citigroup Inc | 6,207 | $7.00K |
| UBS Group AG | 3,551 | $4.00K |